Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Insmed Inc (INSM)

Insmed Inc (INSM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,046,871
  • Shares Outstanding, K 89,344
  • Annual Sales, $ 9,840 K
  • Annual Income, $ -324,280 K
  • 60-Month Beta 3.04
  • Price/Sales 209.85
  • Price/Cash Flow N/A
  • Price/Book 6.79

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.57
  • Number of Estimates 5
  • High Estimate -0.42
  • Low Estimate -0.66
  • Prior Year -1.17
  • Growth Rate Est. (year over year) +51.28%

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.44 +26.30%
on 11/11/19
23.67 -1.61%
on 12/05/19
+4.22 (+22.13%)
since 11/08/19
3-Month
15.99 +45.65%
on 10/10/19
23.67 -1.61%
on 12/05/19
+5.09 (+27.97%)
since 09/10/19
52-Week
11.31 +105.92%
on 12/24/18
33.13 -29.70%
on 04/09/19
+7.26 (+45.29%)
since 12/10/18

Most Recent Stories

More News
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the granting of inducement awards...

INSM : 23.29 (+1.66%)
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CLVS , INSM , GBT , ARWR, SRPT )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

CLVS : 12.10 (+12.98%)
GBT : 75.95 (+1.12%)
INSM : 23.29 (+1.66%)
ARWR : 70.86 (+4.56%)
Insmed to Present at Two December Conferences

Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present at the...

INSM : 23.29 (+1.66%)
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (NVTA , FGEN , INSM , ALKS , GBT )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

FGEN : 48.06 (+0.63%)
INSM : 23.29 (+1.66%)
NVTA : 17.72 (+3.69%)
Insmed Appoints Dr. Clarissa Desjardins to its Board of Directors and Names Roger Adsett Chief Operating Officer

Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the appointment of Clarissa Desjardins,...

CMTA : 26.35 (-0.11%)
INSM : 23.29 (+1.66%)
Insmed to Present at Two November Conferences

Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present at the...

INSM : 23.29 (+1.66%)
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the granting of inducement awards to...

INSM : 23.29 (+1.66%)
Insmed (INSM) in Focus: Stock Moves 7.1% Higher

Insmed (INSM) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

ACOR : 1.69 (-1.74%)
INSM : 23.29 (+1.66%)
Shares of Epizyme Inc Rank the Highest in Terms of Relative Performance in the Biotechnology Industry (EPZM , INSM , PTCT , UTHR , IONS )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

EPZM : 18.81 (+1.18%)
INSM : 23.29 (+1.66%)
PTCT : 48.65 (+0.87%)
SmarTrend Watching for Potential Pullback in Shares of Insmed Inc After 4.69% Gain

Insmed Inc (NASDAQ:INSM) traded in a range yesterday that spanned from a low of $17.62 to a high of $19.10. Yesterday, the shares gained 4.7%, which took the trading range above the 3-day high of $18.43...

INSM : 23.29 (+1.66%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Strengthening short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade INSM with:

Business Summary

Insmed is a biopharmaceutical company engaged in the development and commercialization of ARIKAYCE, or liposomal amikacin for inhalation, for at least two identified orphan patient populations: patients with nontuberculous mycobacteria (NTM) lung infections and cystic fibrosis (CF) patients with Pseudomonas...

See More

Key Turning Points

2nd Resistance Point 23.70
1st Resistance Point 23.49
Last Price 23.29
1st Support Level 22.92
2nd Support Level 22.56

See More

52-Week High 33.13
Fibonacci 61.8% 24.79
Last Price 23.29
Fibonacci 50% 22.22
Fibonacci 38.2% 19.64
52-Week Low 11.31

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar